10x Genomics, Inc. (TXG) is in Healthcare, Medical Devices, based in United States, listed on NasdaqGS. Market cap 10.07B USD. 52-week range 11.16 to 102.81 USD. Data as of 2026-10-09.
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and ...